In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.

Abstract:

:MicroRNAs (miRNAs or miRs) contribute to the development of various malignant neoplasms, including glioblastoma multiforme (GBM). The present study aimed to explore the pathogenesis of GBM and to identify latent therapeutic agents for patients with GBM, based on an in silico analysis. Gene chips that provide miRNA expression profiling in GBM were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed miRNAs (DEMs) were also determined via the RobustRankAggreg algorithm. The target genes of DEMs were predicted and then intersected with GBM‑associated genes that were collected from the Gene Expression Profiling Interactive Analysis. Gene Oncology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses of the overlapping genes were then performed. Simultaneously, a connectivity map (CMap) analysis was performed to screen for potential therapeutic agents for GBM. A total of 10 DEMs (hsa‑miR‑196a, hsa‑miR‑10b, hsa‑miR‑196b, hsa‑miR‑18b, hsa‑miR‑542‑3p, hsa‑miR‑129‑3p, hsa‑miR‑1224‑5p, hsa‑miR‑876‑3p and hsa‑miR‑770‑5p) were obtained from three GEO gene chips (GSE25631, GSE42657 and GSE61710). Then, 1,720 target genes of the 10 miRNAs and 4,185 differently expressed genes in GBM were collected. By intersecting the aforementioned gene clusters, the present study identified 390 overlapping genes. GO and KEGG analyses of the 390 genes demonstrated that these genes were involved in certain cancer‑associated biological functions and pathways. Eight genes [(GTPase NRas (NRAS), calcium/calmodulin‑dependent protein kinase type II subunit Gamma (CAMK2G), platelet‑derived growth factor receptor alpha (PDGFRA), calmodulin 3 (CALM3), cyclin‑dependent kinase 6 (CDK6), calcium/calmodulin‑dependent protein kinase type II subunit beta (CAMK2B), retinoblastoma‑associated protein (RB1) and protein kinase C beta type (PRKCB)] that were centralized in the glioma pathway were selected for CMap analysis. Three chemicals (W‑13, gefitinib and exemestane) were identified as putative therapeutic agents for GBM. In summary, the present study identified three miRNA‑based chemicals for use as a therapy for GBM. However, more experimental data are needed to verify the therapeutic properties of these latent drugs in GBM.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Xiong DD,Xu WQ,He RQ,Dang YW,Chen G,Luo DZ

doi

10.3892/or.2019.7022

subject

Has Abstract

pub_date

2019-04-01 00:00:00

pages

2194-2208

issue

4

eissn

1021-335X

issn

1791-2431

journal_volume

41

pub_type

杂志文章
  • Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape.

    abstract::Homeobox containing 1 (HMBOX1) is a novel transcription repressor that is significantly downregulated in human liver cancer tissues and cell lines, but the exact biological function of HMBOX1 in liver cancer is still unknown. We observed a negative association between HMBOX1 expression level and the clinical stages of...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6551

    authors: Zhao H,Jia H,Han Q,Zhang J

    更新日期:2018-09-01 00:00:00

  • Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.

    abstract::The signal transducer and activator of transcription 3 (STAT3) are ideal targets for ovarian cancer. Previous studies showed that downregulation of STAT3 using specific short hairpin RNAs (shRNA) can significantly reduce ovarian tumor growth. However, RNA interference does not fully ablate target gene expression due t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3623

    authors: Pan Y,Zhang L,Zhang X,Liu R

    更新日期:2015-02-01 00:00:00

  • Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.

    abstract::The promigratory molecule L1CAM is overexpressed in various tumors, often representing an unfavorable prognostic marker. Recently, we identified L1CAM expression in pancreatic ductal adenocarcinoma (PDAC) cells accounting for chemoresistance and increased cell migration. Thus, the present study aims at further elucida...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.909

    authors: Bergmann F,Wandschneider F,Sipos B,Moldenhauer G,Schniewind B,Welsch T,Schirrmacher P,Klöppel G,Altevogt P,Schäfer H,Sebens Müerköster S

    更新日期:2010-10-01 00:00:00

  • Nuclear EpICD expression and its role in hepatocellular carcinoma.

    abstract::Regulated intramembrane proteolysis of epithelial cell adhesion molecule (EpCAM) results in shedding of the extracellular domain (EpEX) and release of the intra-cellular domain (EpICD) into the cytoplasm. Released EpICD associates with FHL2, β-catenin and Lef-1 to form a nuclear complex and triggers oncogenic signalin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4789

    authors: Park SY,Bae JS,Cha EJ,Chu HH,Sohn JS,Moon WS

    更新日期:2016-07-01 00:00:00

  • Genetic progression and divergence in superficial esophageal squamous cell carcinoma by loss of heterozygosity analysis.

    abstract::Esophageal squamous cell carcinoma (SCC) is one of the most common fatal carcinomas worldwide and has some of the most malignant characteristics among gastrointestinal tumors. Although a high frequency of loss of heterozygosity (LOH) for various genes has been observed in esophageal SCCs, these findings do not provide...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shima H,Hiyama T,Tanaka S,Yoshihara M,Arihiro K,Chayama K

    更新日期:2006-10-01 00:00:00

  • Comparative genomics on Fzd8 orthologs.

    abstract::WNT signaling pathway networks with Hedgehog, Notch and FGF signaling pathways during carcinogenesis and embryogenesis. FZD8 is up-regulated in HeLa S3 and A549 cells. Here we identified and characterized rat Fzd8 gene by using bioinformatics. Rat Fzd8 gene was identified within AC131883.2 genome sequence. Rat Fzd8 (6...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Katoh Y,Katoh M

    更新日期:2005-05-01 00:00:00

  • Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.

    abstract::Tumor invasion, angiogenesis and metastasis involve secretion of proteolytic enzymes and cell migration into blood vessels. Tumor cells are capable of degrading the extracellular matrix via a proteolytic cascade that includes urokinase-type plasminogen activator (uPA) and matrix metalloproteases (MMPs). We have invest...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Farina HG,Pomies M,Alonso DF,Gomez DE

    更新日期:2006-10-01 00:00:00

  • Fusion induced reversal of dendritic cell maturation: an altered expression of inflammatory chemokine and chemokine receptors in dendritomas.

    abstract::Dendritic cell-mediated cancer immunotherapy employs several ways to engage tumor antigens. We have demonstrated in both pre-clinical animal studies and early clinical trials that dendritomas, highly purified hybrids between dendritic cells (DC) and tumor cells, are superior activators of anti-tumor immunity. It has b...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Branham-O'Connor M,Li J,Kotturi HS,Yu X,Wagner TE,Wei Y

    更新日期:2010-02-01 00:00:00

  • Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level.

    abstract::Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries, and mainly originates from an accumulation of abnormal B cells caused by the dysregulation of cell proliferation and apoptosis rates. The aberration of apoptosis-related genes in CLL cells results in defective apoptosis of CLL cells i...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4950

    authors: Fu C,Gong Y,Shi X,Sun Z,Niu M,Sang W,Xu L,Zhu F,Wang Y,Xu K

    更新日期:2016-09-01 00:00:00

  • Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.

    abstract::Aberrant expression of microRNAs has been identified as regulators of biological processes of hepatocellular carcinoma (HCC) by negatively regulating protein-coding mRNAs. Several studies have demonstrated that miR-638 expression was dysregulated in various human cancers. However, the clinical significance and underly...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5273

    authors: Zhang Y,Zhang D,Jiang J,Dong L

    更新日期:2017-01-01 00:00:00

  • Rab15 alternative splicing is altered in spheres of neuroblastoma cells.

    abstract::Neuroblastoma is an aggressive pediatric tumor that accounts for 15% of cancer-related deaths in children. More than half of high-risk neuroblastoma patients develop tumor relapse that is lethal in most cases. A small population of tumor-initiating cells (TICs), recently identified from high-risk neuroblastoma patient...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1731

    authors: Pham TV,Hartomo TB,Lee MJ,Hasegawa D,Ishida T,Kawasaki K,Kosaka Y,Yamamoto T,Morikawa S,Yamamoto N,Kubokawa I,Mori T,Yanai T,Hayakawa A,Takeshima Y,Iijima K,Matsuo M,Nishio H,Nishimura N

    更新日期:2012-06-01 00:00:00

  • Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.

    abstract::Chemotherapy is one of the methods to treat patients with non-small cell lung cancer (NSCLC) developing resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), such as gefitinib. Previous studies revealed that the sensitivity to chemotherapy may depend on different cellular mechanisms ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6242

    authors: Zhou J,Hu Q,Zhang X,Zheng J,Xie B,Xu Z,Zhang W

    更新日期:2018-04-01 00:00:00

  • MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.

    abstract::The roles and mechanisms of mini-chromosome maintenance complex component 7 (MCM7) amplification and overexpression in esophageal carcinogenesis were investigated. By analyzing the TCGA datasets, we found that MCM7 was amplified in approximately 12% of esophageal squamous cell carcinomas (ESCCs), and in more than 4% o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5614

    authors: Qiu YT,Wang WJ,Zhang B,Mei LL,Shi ZZ

    更新日期:2017-06-01 00:00:00

  • Actin disruption agents induce phosphorylation of histone H2AX in human breast adenocarcinoma MCF-7 cells.

    abstract::Modified actin dynamics are a unique feature of transformed cancer cells and thereby promising targets for cancer chemotherapy. While latrunculin B (LB) and pectenotoxin-2 (PTX-2), both derived from natural sources, inhibit actin polymerization, jasplakinolide (JSP) prevents actin depolymerization. The purpose of this...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1214

    authors: Shin IJ,Ahn YT,Kim Y,Kim JM,An WG

    更新日期:2011-05-01 00:00:00

  • Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.

    abstract::Cervical cancer is the second most common gynecological malignancy. The mechanisms of the genesis and progression of cervical cancer are complicated and not thoroughly understood. DEK is reported as an oncogene in various cancers, such as acute myeloid leukemia, bladder cancer, breast cancer and hepatocellular cancer....

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5721

    authors: Xu X,Zou L,Yao Q,Zhang Y,Gan L,Tang L

    更新日期:2017-08-01 00:00:00

  • 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.

    abstract::The metabolism of arachidonic acid by either the cyclooxygenase or lipoxygenase (LOX) pathway is believed to play an important role in tumor promotion. We investigated the expression of 5- and 12-LOX in renal cell carcinoma (RCC), as well as the effects of their inhibitors on cell proliferation in 2 RCC cell lines (Ca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Matsuyama M,Yoshimura R,Mitsuhashi M,Tsuchida K,Takemoto Y,Kawahito Y,Sano H,Nakatani T

    更新日期:2005-07-01 00:00:00

  • Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway.

    abstract::Sedum sarmentosum Bunge, a traditional Chinese herbal medicine, has a wide range of clinical applications including antibiosis, anti-inflammation and anti-oxidation. In the present study, we identified that its extract (SSBE) exerts pancreatic anticancer activity in vitro and in vivo. In the cultured pancreatic cancer...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4679

    authors: Bai Y,Chen B,Hong W,Liang Y,Zhou M,Zhou L

    更新日期:2016-05-01 00:00:00

  • Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence.

    abstract::Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 3 is involved in calcium mobilization from the endoplasmic reticulum into the cytosol and is closely linked to metabolism, neuronal plasticity, gene transcription, cell growth, differentiation, apoptosis, protein folding and carcinogenesis. In order to elucidate the role...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2837

    authors: Gou WF,Niu ZF,Zhao S,Takano Y,Zheng HC

    更新日期:2014-01-01 00:00:00

  • Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience.

    abstract::Sunitinib is a novel, multi-targeted receptor tyrosine kinase inhibitor, which has demonstrated evidence of improved survival when compared to interferon (IFN)-alpha in patients with metastatic renal cell carcinoma (RCC). Recently published National Institute for Health and Clinical Excellence guidance recommends suni...

    journal_title:Oncology reports

    pub_type: 临床试验,杂志文章

    doi:10.3892/or_00000886

    authors: Ansari J,Fatima A,Fernando K,Collins S,James ND,Porfiri E

    更新日期:2010-08-01 00:00:00

  • Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.

    abstract::Endocannabinoids and ceramides have demonstrated growth inhibition, cell death induction and pro-apoptotic activity in cancer research. In the present study, we describe the profiles of two major endocannabinoids, ceramides, free fatty acids and relevant metabolic enzymes in 47 pairs of human colorectal cancer tissues...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3973

    authors: Chen L,Chen H,Li Y,Li L,Qiu Y,Ren J

    更新日期:2015-07-01 00:00:00

  • Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells.

    abstract::In order to clarify the molecular mechanism involved in renal carcinogenesis, and to identify molecular targets for development of novel treatments of renal cell carcinoma (RCC), we previously analyzed genome-wide gene expression profiles of clear-cell types of RCC by cDNA microarray. Among the transcativated genes, w...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Dobashi S,Katagiri T,Hirota E,Ashida S,Daigo Y,Shuin T,Fujioka T,Miki T,Nakamura Y

    更新日期:2009-02-01 00:00:00

  • Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.

    abstract::The objective of this study was to investigate the effect of silencing gene protein phosphatase 1H (PPM1H) on malignant phenotype of human pancreatic cancer cell line BxPC-3. In order to explore the function of PPM1H in pancreatic cancer cells, real-time PCR and western blotting were used to detect the expression of P...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5065

    authors: Zhu H,Qin H,Li DM,Liu J,Zhao Q

    更新日期:2016-11-01 00:00:00

  • Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway.

    abstract::The peroxisome proliferator-activated receptor-γ (PPAR-γ) coactivator-1β (PGC-1β) is a well-established regulator of mitochondrial biogenesis. However, the underlying mechanism of PGC-1β action remains elusive. This study reveals that knockdown of endogenous PGC-1β by short-hairpin RNA (shRNA) leads to a decrease in t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2628

    authors: Wang L,Liu Q,Li F,Qiu J,Fan H,Ma H,Zhu Y,Wu L,Han X,Yang Z,Jiang H,Wei J,Xia H

    更新日期:2013-10-01 00:00:00

  • Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore.

    abstract::Chronic hepatitis B virus (HBV) infection is a leading cause of liver cirrhosis and cancer. Among the pathogenic factors of HBV, HBV X protein (HBx) is attracting increased attention. Although it is documented that HBx is a multifunctional regulator that modulates cell inflammation and apoptosis, the exact mechanism r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5225

    authors: Gao WY,Li D,Cai DE,Huang XY,Zheng BY,Huang YH,Chen ZX,Wang XZ

    更新日期:2017-01-01 00:00:00

  • Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.

    abstract::Patient survival in pancreatic cancer remains poor with gemcitabine (GEM)-based regimens. The target specific molecular agent lapatinib, a dual ErbB1 and ErbB2 receptor tyrosine kinase inhibitor, has shown significant activity against ErbB1 and ErbB2-expressing tumors. Since pancrea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2053

    authors: Singla S,Pippin JA,Drebin JA

    更新日期:2012-12-01 00:00:00

  • Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.

    abstract::Hyaluronan (HA), a component of the extracellular matrix, plays an important role in cell-cell adhesion and cell migration. Membrane type 1-matrix metalloproteinase (MT1‑MMP) is often expressed in invasive cancer cells. CD44, a transmembrane receptor for HA, is implicated in various adhesion-dependent cellular process...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1993

    authors: Kung CI,Chen CY,Yang CC,Lin CY,Chen TH,Wang HS

    更新日期:2012-11-01 00:00:00

  • Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.

    abstract::The carcinogenic role of hepatitis B virus x protein (HBx) in hepatocellular carcinoma (HCC) remains largely unknown. Centromere protein A (CENP-A) has been found to be frequently overexpressed in HCC. In the present study, we aimed to investigate the role of HBx in regulating CENP-...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1478

    authors: Liu L,Li Y,Zhang S,Yu D,Zhu M

    更新日期:2012-01-01 00:00:00

  • Few genes are associated with the capability of pancreatic ductal adenocarcinoma cells to grow in the liver of nude rats.

    abstract::Owing to aggressiveness and chemoresistance, pancreatic ductal adenocarcinoma (PDAC) is characterised by a poor prognosis. To address this disease-spe-cific dilemma we aimed to establish animal models, which can be used for identifying new specific tumor markers, as well as serving ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2049

    authors: Eyol E,Murtaga A,Zhivkova-Galunska M,Georges R,Zepp M,Djandji D,Kleeff J,Berger MR,Adwan H

    更新日期:2012-12-01 00:00:00

  • The antitumor effect of human cord blood-derived dendritic cells modified by the livin α gene in lung cancer cell lines.

    abstract::The growth of malignant tumors is associated with mechanisms of immune escape and inhibition of apoptosis. Livin is a novel member of the inhibitors of apoptosis (IAP) protein family that inhibits cell apoptosis. Livin is specifically expressed by the majority of tumor cells, but it is not expressed in normal adult ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2133

    authors: Chen H,Jin Y,Chen T,Zhang M,Ma W,Xiong X,Tao X

    更新日期:2013-02-01 00:00:00

  • DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.

    abstract::DNA damage sensor proteins are recognized as upstream components of the DNA damage checkpoint signaling pathway and are required for cell cycle control and the induction of apoptosis. hRad9 plays an important role as an upstream regulator of checkpoint signaling. In our previous studies, we confirmed the significant a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yuki T,Maniwa Y,Doi T,Okada K,Nishio W,Hayashi Y,Okita Y

    更新日期:2008-11-01 00:00:00